Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: Clinical features and response to therapy

Hepatology

Volumn 28, Issue 2, 1998, Pages 296-301

  Chazouillères, Olivier ^a,b   Wendum, Dominique ^a   Serfaty, Lawrence ^a   Montembault, Sarah ^a   Rosmorduc, Olivier ^a   Poupon, Raoul ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AUTOANTIBODY; AZATHIOPRINE; CORTICOSTEROID; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; CLINICAL FEATURE; CORTICOSTEROID THERAPY; CUSHINGOID SYNDROME; DIABETES MELLITUS; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; VERTEBRA FRACTURE;

ADRENAL CORTEX HORMONES; ADULT; AGED; CHOLAGOGUES AND CHOLERETICS; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; SYNDROME; TREATMENT OUTCOME; URSODEOXYCHOLIC ACID;

EID: 0031879659     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510280203     Document Type: Article

References (19)

1. Geubel AP, Baggenstoss AH, Summerskill WHJ. Responses to treatment can differentiate chronic active liver disease with cholangitic feactures from the primary biliary cirrhosis syndrome. Gastroenterology 1976;71:444-449.
2. Kloppel G, Seifert G, Lindner H, Dammermann R, Sack HJ, Berg PA. Histopathological features in mixed types of chronic aggressive hepatitis and primary biliary cirrhosis. Virchows Arch A Pathol Anal Histopathol 1977;373:143-160.
3. Shouval D, Levij IS, Eliakim M. Chronic active hepatitis with cholestatic features. Am J Gastroenterol 1979;72:542-550.
4. Okuno T, Seto Y, Okanoue T, Takino T. Chronic active hepatitis with histological features of primary biliary cirrhosis. Dig Dis Sci 1987;32:775-779.
5. Carrougher JG, Shaffer RT, Canales LI, Goodman ZD. A 33-year-old woman with an autoimmune syndrome. Semin Liver Dis 1991;11:256-262.
6. Davis PA, Leung P, Manns M, Kaplan M, Munoz SJ, Gorin FA, Dickson ER, et al. M4 and M9 antibodies in the overlap syndrome of primary biliary cirrhosis and chronic active hepatitis: epitopes or epiphenomena? HEPATOLOGY 1992;16:1128-1136.
7. Ben-Ari Z, Dhillon AP, Sherlock S. Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis. HEPATOLOGY 1993;18:10-15.
8. Colombato LA, Alvarez F, Cote J, Huet PM. Autoimmune cholangiopathy: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis? Gastroenterology 1994;107:1839-1843.
9. Duclos-Vallée JC, Hadengue A, Ganne-Carrie N, Robin E, Degott C, Erlinger S. Primary biliary cirrhosis - autoimmune hepatitis overlap syndrome. Corticoresistance and effective treament by cyclosporine A. Dig Dis Sci 1995;40:1069-1073.
10. Perrillo RP, Mason AL, Jacob S, Gerber MA. Hepatitis and cholestasis in a middle-aged woman. HEPATOLOGY 1996;24:730-734.
11. Dubel L, Farges O, Bismuth H, Sebagh M, Homberg JC, Johanet C. Kinetics of anti-M2 antibodies after liver transplantation for primary biliary cirrhosis. J Hepatol 1995;23:674-680.
12. Ludwig J, Dickson ER, McDonald GSA. Staging of chronic non-suppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anal Histopathol 1978;379:103-112.
13. The METAVIR Cooperative Group. Inter- and intra-observer variation in the assessment of liver biopsy of chronic hepatitis C. HEPATOLOGY 1994;20:15-20.
14. Bedossa P, Poynard T. for the METAVIR cooperative study group. An algorithm for the grading of activity in chronic hepatitis C. HEPATOLOGY 1996;24:289-293.
15. Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1996;335:1570-1580.
16. Krawitt EL. Autoimmune hepatitis. N Engl J Med 1996;334:897-903.
17. Kenny RP, Czaja AJ, Ludwig J, Dickson ER. Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis. Dig Dis Sci 1986;31:705-711.
18. Czaja AJ, Carpenter HA, Manns MP. Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis. Gastroenterology 1993;105:1522-1528.
19. Vyberg M. The hepatitis-associated bile duct lesion. Liver 1993;13:289-301.